Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.1 mm RC, SLActive 12 mm: medical device reports filed with FDA

1,057 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,057
device reports naming the brand
0% of all MAUDE reports · about 153 a year
108
reports, 12 months to August 2026
136 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,057 medical device reports received by FDA name the brand "BL, ? 4.1 mm RC, SLActive 12 mm" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from August 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

108 reports arrived in the 12 months to August 2026, down 21% from 136 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are loss of osseointegration (82.2%), failure to osseointegrate (12.4%) and fracture (5.9%). The patient problems coded most often are fibrosis, pain and hemorrhage/blood loss/bleeding. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01734Sep 2021: 16Oct 2021: 24Nov 2021: 20Dec 2021: 122022Jan 2022: 18Feb 2022: 11Mar 2022: 7Apr 2022: 6May 2022: 28Jun 2022: 10Jul 2022: 10Aug 2022: 9Sep 2022: 6Oct 2022: 14Nov 2022: 12Dec 2022: 162023Jan 2023: 7Feb 2023: 16Mar 2023: 15Apr 2023: 13May 2023: 13Jun 2023: 7Jul 2023: 7Aug 2023: 14Sep 2023: 12Oct 2023: 14Nov 2023: 12Dec 2023: 122024Jan 2024: 7Feb 2024: 8Mar 2024: 14Apr 2024: 14May 2024: 15Jun 2024: 5Jul 2024: 12Aug 2024: 19Sep 2024: 13Oct 2024: 13Nov 2024: 14Dec 2024: 72025Jan 2025: 9Feb 2025: 13Mar 2025: 6Apr 2025: 4May 2025: 0Jun 2025: 34Jul 2025: 8Aug 2025: 15Sep 2025: 6Oct 2025: 3Nov 2025: 8Dec 2025: 122026Jan 2026: 5Feb 2026: 13Mar 2026: 7Apr 2026: 8May 2026: 14Jun 2026: 8Jul 2026: 9Aug 2026: 15

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0841682019: 13420192020: 12820202021: 16820212022: 14720222023: 14220232024: 14120242025: 11820252026: 792026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,057
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report90.2%953
Voluntary report0%0
User facility report0%0
Distributor report9.8%104
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Loss of osseointegration86982.2%22.4%
Failure to osseointegrate13112.4%62.8%
Fracturea broken bone625.9%1.6%
Difficult to removethe device was hard to remove20.2%0%
Separation failure10.1%0.1%
Unintended movement10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis23822.5%
Painpain, site not specified20819.7%
Hemorrhage/blood loss/bleeding20619.5%
Inflammationinflammation19018%
Swelling/ edema12111.4%
Tissue damage11110.5%
Abscessa collection of pus504.7%
Fistula484.5%
Failure of implant201.9%
Hyperresponsive to stimuli181.7%
Hypersensitivity/allergic reaction151.4%
Swellingswelling131.2%
Increased sensitivity80.8%
Sinus perforation40.4%
Inadequate osseointegration10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.1 mm RC, SLActive 12 mmProduct code DZEAll MAUDE reports
Reports1,0573,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer90.2%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.1 mm RC, SLActive 12 mm reports

How many FDA reports name BL, ? 4.1 mm RC, SLActive 12 mm?

1,057 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 108 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

loss of osseointegration (82.2%), failure to osseointegrate (12.4%), fracture (5.9%), difficult to remove (0.2%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (90.2%) and distributor reports (9.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.1 mm RC, SLActive 12 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.